In return, Cancer Research UK and Newcastle University are eligible to receive milestone and royalty payments on any compounds that Astex takes into clinical development and successfully commercialises. Dr Iain Foulkes, Cancer Research UK's executive ... #cancerresearch
No comments:
Post a Comment